A new study published in the International Journal of Chronic Obstructive Pulmonary Disease showed a non-linear association ...

Increasing evidence indicates that aging contributes to the risk for chronic respiratory diseases, but the impact of ...

Treatment Devices Market is set to grow at a CAGR of 6.35% from 2025 to 2032. This surge is driven by rising COPD prevalence due to factors like tobacco smoking and air pollution, increased awareness, ...

The presence of gastroesophageal reflux disease (GERD) is associated with an increased incidence of pulmonary diseases, but ...

A new study will investigate whether levels of the lung protein CC16 in childhood can predict risk of early chronic ...

The participants will receive either 100 mg of verekitug every 12 weeks, 400 mg every 24 weeks, or a placebo, throughout 60 ...

The diagnosis of chronic obstructive pulmonary disease, or COPD, is improved by incorporating CT lung imaging and respiratory ...

Patients who regularly use antiemetic medication, such as for nausea from chemotherapy, appear at increased risk for chronic kidney disease. Patients who use antiemetics have an increased risk of ...

AstraZeneca has completed a Phase 3 clinical study titled ‘RESOLUTE,’ aimed at evaluating the efficacy and safety of Benralizumab in patients with moderate to very severe Chronic Obstructive Pulmonary ...

Another question raised by the trial was whether the greater number of deaths in the minimal-equipment group (15 vs 6, P ...

Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.

International and local healthcare experts met in Danang August 16–17 to discuss infectious disease prevention and the role ...